Novel quantitative method to evaluate globotriaosylceramide inclusions in renal peritubular capillaries by virtual microscopy in patients with fabry disease

Archives of Pathology and Laboratory Medicine

Volumn 136, Issue 7, 2012, Pages 816-824

  Barisoni, Laura ^a   Jennette, J Charles ^b   Colvin, Robert ^c   Sitaraman, Sheela ^d   Bragat, Alexander ^d   Castelli, Jeff ^d   Walker, Dan ^e   Boudes, Pol ^d  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Amicus Therapeutics Inc   (United States)

^e Aperio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE TRIHEXOSIDE; GLOBOTRIAOSYLCERAMIDE;

ARTICLE; CAPILLARY; FABRY DISEASE; FEMALE; HUMAN; KIDNEY; MALE; METABOLISM; METHODOLOGY; MICROSCOPY; PATHOLOGY; ULTRASTRUCTURE; VASCULARIZATION;

CAPILLARIES; FABRY DISEASE; FEMALE; HUMANS; KIDNEY; MALE; MICROSCOPY; TRIHEXOSYLCERAMIDES;

EID: 84864261116     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2011-0350-OA     Document Type: Article

References (19)

1. Hughes DA, Barba Romero MÁ, Hollak CE, Giugliani R, Deegan PB. Response of women with Fabry disease to enzyme replacement therapy; comparison with men, using data from FOS-the Fabry Outcome Survey. Mol Genet Metab. 2011;103(3):207-214.
2. Thurberg BL, Rennke H, Colvin RB, et al. Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int. 2002;62(6):1933-1946. (Pubitemid 35366149)
3. Schaefer RM, Tylki-Szymanska A, Hilz MJ. Enzyme replacement therapy for Fabry disease: a systematic review of available evidence. Drugs. 2009;69(16): 2179-2205.
4. Schiffmann R, Brady RO. New prospects for the treatment of lysosomal storage diseases. Drugs. 2002;62(5):733-742. (Pubitemid 34494019)
5. Hughes DA, Barba Romero MA, Hollak CE, Giugliani R, Deegan PB. Response of women with Fabry disease to enzyme replacement therapy: comparison with men, using data from FOS-the Fabry Outcome Survey. Mol Genet Metab. 2011;103(3):207-214.
6. Najafian B, Svarstad E, Bostad L, et al. Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney Int. 2011;79(6):663-670.
7. Warnock DG, Ortiz A, Mauer M, et al. Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation [published online ahead of print July 29, 2011]. Nephrol Dial Transplant. doi: 10.1093/ndt/gfr420.
8. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307-310. (Pubitemid 16134762)
9. Roberts IS, Cook HT, Troyanov S, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76(5):546-556.
10. Weinstein RS, Graham AR, Richter LC, et al. Overview of telepathology, virtual microscopy, and whole slide imaging: prospects for the future. Hum Pathol. 2009;40(8):1057-1069.
11. Afework A, Beynon MD, Bustamante F, et al. Digital dynamic telepathology-the Virtual Microscope. Proc AMIA Symp. 1998:912-916.
12. Lee SH. Virtual microscopy: applications to hematology education and training. Hematology. 2005;10(suppl 1):151-153.
13. Paulsen FP, Eichhorn M, Brauer L. Virtual microscopy-the future of teaching histology in the medical curriculum? Ann Anat. 2010;192(6):378-382.
14. Arnes JB, Begin LR, Stefansson I, et al. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer. J Clin Pathol. 2009;62(2):139-146.
15. Furness P. A randomized controlled trial of the diagnostic accuracy of internet-based telepathology compared with conventional microscopy. Histopathology. 2007;50(2):266-273. (Pubitemid 46046396)
16. Furness P, Rashbass J. The virtual double-headed microscope: telepathology for all? Histopathology. 2000;36(2):182-183. (Pubitemid 30113982)
17. Grabe N, Lahrmann B, Pommerencke T, von Knebel Doeberitz M, Reuschenbach M, Wentzensen N. A virtual microscopy system to scan, evaluate and archive biomarker enhanced cervical cytology slides. Cell Oncol. 2010; 32(1-2):109-119.
18. Lopez AM, Graham AR, Barker GP, et al. Virtual slide telepathology enables an innovative telehealth rapid breast care clinic. Hum Pathol. 2009; 40(8):1082-1091.
19. Nielsen PS, Lindebjerg J, Rasmussen J, Starklint H, Waldstrom M, Nielsen B. Virtual microscopy: an evaluation of its validity and diagnostic performance in routine histologic diagnosis of skin tumors. Hum Pathol. 2010;41(12):1770- 1776.